Gilenya Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Safety and Efficacy Study of Fingolimod in Taiwanese Adults ( ≥ 20years) With Relapsing Remitting Multiple Sclerosis
Condition:   Multiple Sclerosis Intervention:   Drug: Fingolimod Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2020 Category: Research Source Type: clinical trials

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Dimethyl Fumarate or Fingolimod to Ofatumumab
Condition:   Relapsing Multiple Sclerosis Intervention:   Biological: Ofatumumab Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2020 Category: Research Source Type: clinical trials